|
1
|
Pimple SA and Mishra GA: Global strategies
for cervical cancer prevention and screening. Minerva Ginecol.
71:313–320. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bhatla N and Singhal S: Primary HPV
screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol.
65:98–108. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stumbar SE, Stevens M and Feld Z: Cervical
cancer and its precursors: A preventative approach to screening,
diagnosis, and management. Prim Care. 46:117–134. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun Y, Yang X, Liu M and Tang H:
Corrigendum to ‘B4GALT3 up-regulation by miR-27a contributes to the
oncogenic activity in human cervical cancer cells.’ [Canc. Lett.
375 (2016) 284-292]. Cancer Lett. 493:16–18. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zelinski DP, Zantek ND, Stewart JC,
Irizarry AR and Kinch MS: EphA2 overexpression causes tumorigenesis
of mammary epithelial cells. Cancer Res. 61:2301–2306.
2001.PubMed/NCBI
|
|
8
|
Walker-Daniels J, Coffman K, Azimi M, Rhim
JS, Bostwick DG, Snyder P, Kerns BJ, Waters DJ and Kinch MS:
Overexpression of the EphA2 tyrosine kinase in prostate cancer.
Prostate. 41:275–280. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyazaki T, Kato H, Fukuchi M, Nakajima M
and Kuwano H: EphA2 overexpression correlates with poor prognosis
in esophageal squamous cell carcinoma. Int J Cancer. 103:657–663.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kinch MS, Moore MB and Harpole DH Jr:
Predictive value of the EphA2 receptor tyrosine kinase in lung
cancer recurrence and survival. Clin Cancer Res. 9:613–618.
2003.PubMed/NCBI
|
|
11
|
Zeng G, Hu Z, Kinch MS, Pan CX, Flockhart
DA, Kao C, Gardner TA, Zhang S, Li L, Baldridge LA, et al:
High-level expression of EphA2 receptor tyrosine kinase in
prostatic intraepithelial neoplasia. Am J Pathol. 163:2271–2276.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu D, Suo Z, Kristensen GB, Li S, Troen G,
Holm R and Nesland JM: Prognostic value of EphA2 and EphrinA-1 in
squamous cell cervical carcinoma. Gynecol Oncol. 94:312–319. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng L, Li K, Wei H, Hu J, Jiao L, Yu S
and Xiong Y: A novel EphA2 inhibitor exerts beneficial effects in
PI–IBS in vivo and in vitro models via Nrf2 and NF-κB signaling
pathways. Front Pharmacol. 9:2722018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong HN, Won YJ, Shim JH, Kim HJ, Han SH,
Kim BS and Kim HS: Cancer-associated fibroblasts promote gastric
tumorigenesis through EphA2 activation in a ligand-independent
manner. J Cancer Res Clin Oncol. 144:1649–1663. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ishigaki H, Minami T, Morimura O, Kitai H,
Horio D, Koda Y, Fujimoto E, Negi Y, Nakajima Y, Niki M, et al:
EphA2 inhibition suppresses proliferation of small-cell lung cancer
cells through inducing cell cycle arrest. Biochem Biophys Res
Commun. 519:846–853. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng G, Sun B, Liu HX, Liu QH, Zhao L and
Wang TL: EphA2 antagonism alleviates LPS-induced acute lung injury
via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways. Int
Immunopharmacol. 72:176–185. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yuan B, Cui J, Wang W and Deng K: Gα12/13
signaling promotes cervical cancer invasion through the
RhoA/ROCK-JNK signaling axis. Biochem Biophys Res Commun.
473:1240–1246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou C, Zhuang Z, Deng X, Xu Y, Zhang P and
Zhu L: Knockdown of Trio by CRISPR/Cas9 suppresses migration and
invasion of cervical cancer cells. Oncol Rep. 39:795–801.
2018.PubMed/NCBI
|
|
19
|
Liu X, Chen D and Liu G: Overexpression of
RhoA promotes the proliferation and migration of cervical cancer
cells. Biosci Biotechnol Biochem. 78:1895–1901. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng Q, Chen L, Wu W, Wang J, Zheng X,
Chen Z, Jiang Q, Han J, Wei L, Wang L, et al: EPH receptor A2
governs a feedback loop that activates Wnt/β-catenin signaling in
gastric cancer. Cell Death Dis. 9:11462018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XP, He HL, Hu SL, Han JB, Huang LL, Xu
JY, Xie JF, Liu AR, Yang Y and Qiu HB: Ang II-AT2R increases
mesenchymal stem cell migration by signaling through the FAK and
RhoA/Cdc42 pathways in vitro. Stem Cell Res Ther. 8:1642017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res.
45(W1):W98–W102. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cancer Genome Atlas Research Network,
Albert Einstein College of Medicine; Analytical Biological
Services; Barretos Cancer Hospital; Baylor College of Medicine;
Beckman Research Institute of City of Hope; Buck Institute for
Research on Aging; Canada's Michael Smith Genome Sciences Centre;
Harvard Medical School, . Helen F, et al: Integrated genomic and
molecular characterization of cervical cancer. Nature. 543:378–384.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yee GP, de Souza P and Khachigian LM:
Current and potential treatments for cervical cancer. Curr Cancer
Drug Targets. 13:205–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Olusola P, Banerjee HN, Philley JV and
Dasgupta S: Human papilloma virus-associated cervical cancer and
health disparities. Cells. 8:6222019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goodman A: HPV testing as a screen for
cervical cancer. BMJ. 350:h23722015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tandon M, Vemula SV and Mittal SK:
Emerging strategies for EphA2 receptor targeting for cancer
therapeutics. Expert Opin Ther Targets. 15:31–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wykosky J and Debinski W: The EphA2
receptor and ephrinA1 ligand in solid tumors: Function and
therapeutic targeting. Mol Cancer Res. 6:1795–1806. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garcia-Monclus S, Lopez-Alemany R,
Almacellas-Rabaiget O, Herrero-Martín D, Huertas-Martinez J,
Lagares-Tena L, Alba-Pavón P, Hontecillas-Prieto L, Mora J, de
Álava E, et al: EphA2 receptor is a key player in the metastatic
onset of Ewing sarcoma. Int J Cancer. 143:1188–1201. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Finney AC, Funk SD, Green JM, Yurdagul A
Jr, Rana MA, Pistorius R, Henry M, Yurochko A, Pattillo CB, Traylor
JG, et al: EphA2 expression regulates inflammation and
fibroproliferative remodeling in atherosclerosis. Circulation.
136:566–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abraham S, Knapp DW, Cheng L, Snyder PW,
Mittal SK, Bangari DS, Kinch M, Wu L, Dhariwal J and Mohammed SI:
Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary
bladder. Clin Cancer Res. 12:353–360. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou H, Sun Y, Zhang L, Kang W, Li N and
Li Y: The RhoA/ROCK pathway mediates high glucose-induced
cardiomyocyte apoptosis via oxidative stress, JNK, and p38MAPK
pathways. Diabetes Metab Res Rev. 34:e30222018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan J, Chen L, Xiao J, Qi XK, Zhang J, Li
X, Wang Z, Lian YF, Xiang T, Zhang Y, et al: SHROOM2 inhibits tumor
metastasis through RhoA-ROCK pathway-dependent and -independent
mechanisms in nasopharyngeal carcinoma. Cell Death Dis. 10:582019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li D, Wang H, Ding Y, Zhang Z, Zheng Z,
Dong J, Kim H, Meng X, Zhou Q, Zhou J, et al: Targeting the
NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514,
to suppress breast cancer progression and lung metastasis. Cancer
Lett. 424:97–108. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He M, Cheng Y, Li W, Liu Q, Liu J, Huang J
and Fu X: Vascular endothelial growth factor C promotes cervical
cancer metastasis via up-regulation and activation of
RhoA/ROCK-2/moesin cascade. BMC Cancer. 10:1702010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Khumkhrong P, Piboonprai K, Chaichompoo W,
Pimtong W, Khongkow M, Namdee K, Jantimaporn A, Japrung D,
Asawapirom U, Suksamrarn A and Iempridee T: Crinamine induces
apoptosis and inhibits proliferation, migration, and angiogenesis
in cervical cancer SiHa cells. Biomolecules. 9:4942019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Suprynowicz FA, Upadhyay G, Krawczyk E,
Kramer SC, Hebert JD, Liu X, Yuan H, Cheluvaraju C, Clapp PW,
Boucher RC Jr, et al: Conditionally reprogrammed cells represent a
stem-like state of adult epithelial cells. Proc Natl Acad Sci USA.
109:20035–20040. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masuda Y, Takahashi H and Hatakeyama S:
TRIM29 regulates the p63-mediated pathway in cervical cancer cells.
Biochim Biophys Acta. 1853:2296–2305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hazawa M, Lin DC, Handral H, Xu L, Chen Y,
Jiang YY, Mayakonda A, Ding LW, Meng X, Sharma A, et al: ZNF750 is
a lineage-specific tumour suppressor in squamous cell carcinoma.
Oncogene. 36:2243–2254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hazawa M, Lin DC, Kobayashi A, Jiang YY,
Xu L, Dewi FRP, Mohamed MS, Hartono .Nakada M, Meguro-Horike M, et
al: ROCK-dependent phosphorylation of NUP62 regulates p63 nuclear
transport and squamous cell carcinoma proliferation. EMBO Rep.
19:73–88. 2018. View Article : Google Scholar : PubMed/NCBI
|
